ReviewLeukemia2021

Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis.

Moshe Talpaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.